Area of research
Cancer Research · Applied Microbiology and Biotechnology
Research interest
Research focused on RANKL and Cancer research, with related work in Autophagy, Cell biology, Osteoclast. Notable publications include 'Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis', 'NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors', and 'K lotho suppresses tumor progression via inhibiting PI 3 K / A kt/ GSK 3β/Snail signaling in renal cell carcinoma'.
NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors
Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis
<scp>K</scp>lotho suppresses tumor progression via inhibiting <scp>PI</scp>3<scp>K</scp>/<scp>A</scp>kt/<scp>GSK</scp>3β/Snail signaling in renal cell carcinoma
Sunitinib induces cellular senescence via p53/<scp>D</scp>ec1 activation in renal cell carcinoma cells